<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
  dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
  <?SourceDTD.Version 1.2?>
  <?ConverterInfo.XSLTName jats2jats3.xsl?>
  <?ConverterInfo.Version 1?>
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="iso-abbrev">Arch Pharm Pract</journal-id>
      <journal-id journal-id-type="publisher-id">archivepp.com</journal-id>
      <journal-id journal-id-type="publisher-id">Arch Pharm Pract</journal-id>
      <journal-title-group>
        <journal-title>Archives of Pharmacy Practice</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2320-5210</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">archivepp.com-1212</article-id>
      <article-id pub-id-type="doi">10.51847/EOs24fQ0wJ</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Novel Analytical Method for Combined Dapagliflozin and Vildagliptin in Bulk and Pharmaceutical Dosage Form Using HPLC</article-title>
      </title-group>
                    <contrib-group>
                      <contrib contrib-type="author">
              <name>
                <surname>Khagga</surname>
                <given-names>Bhavyasri</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                                            <xref rid="cor1" ref-type="corresp" />
                          </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Nandini</surname>
                <given-names>Musquri</given-names>
              </name>
                              <xref rid="aff2" ref-type="aff">2</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Sowjanya</surname>
                <given-names>Danda</given-names>
              </name>
                              <xref rid="aff3" ref-type="aff">3</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Rambabu</surname>
                <given-names>Dammu</given-names>
              </name>
                              <xref rid="aff4" ref-type="aff">4</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Mogili</surname>
                <given-names>Sumakanth</given-names>
              </name>
                              <xref rid="aff5" ref-type="aff">5</xref>
                                        </contrib>
                  </contrib-group>
                  <aff id="aff1">
            <label>1</label>Department of Pharmaceutical Analysis, RBVRR Women’s College of Pharmacy, Barkatpura, Hyderabad-500027, India


 
          </aff>
                  <aff id="aff2">
            <label>2</label>Department of Pharmaceutical Analysis, RBVRR Women’s College of Pharmacy, Barkatpura, Hyderabad-500027, India. 


 
          </aff>
                  <aff id="aff3">
            <label>3</label>Department of Pharmaceutical Analysis, RBVRR Women’s College of Pharmacy, Barkatpura, Hyderabad-500027, India.
          </aff>
                  <aff id="aff4">
            <label>4</label>Gland Pharma Pvt. Ltd, Hyderabad, India. 


 
          </aff>
                  <aff id="aff5">
            <label>5</label>Department of Pharmaceutical Chemistry, RBVRR Women’s College of Pharmacy, Barkatpura, Hyderabad-500027, India.
          </aff>
                          <author-notes>
            <corresp id="cor1">
              <bold>Address for correspondence:</bold> Prof. Wael Abu Dayyih, Department of
              Pharmaceutical Chemistry, Faculty of Pharmacy, Mutah University, Al-Karak 61710, Jordan.
                              E-mail: <email xlink:href="bhavya.kagga@gmail.com">bhavya.kagga@gmail.com</email>
                          </corresp>
          </author-notes>
                    <pub-date pub-type="epub">
        <day>14</day>
        <month>10</month>
        <year>2024</year>
      </pub-date>
      <volume>15</volume>
      <issue>4</issue>
      <fpage>5</fpage>
      <lpage>9</lpage>
      <permissions>
        <copyright-statement>
          Copyright: &#x000a9; 2026 Archives of Pharmacy Practice
        </copyright-statement>
        <copyright-year>2026</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/"
            specific-use="textmining" content-type="ccbyncsalicense">
            https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
          <license-p>This is an open access journal, and articles are distributed under the terms of
            the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows
            others to remix, tweak, and build upon the work non-commercially, as long as appropriate
            credit is given and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>A<sc>BSTRACT</sc></title>
        <p>A straightforward, exact, and reliable method has been devised to measure Dapagliflozin and Vildagliptin in bulk or combined tablet dose form concurrently by RP-HPLC. The chromatographic conditions used were an Agilent C18 column (150 x 4.6 mm, 5 mm) with a gradient mode of Orthophosphoric acid: Acetonitrile (pH5) as the mobile phase and a flow rate of 0.7 ml/min. The maximum absorbance was determined to be 224nm by UV Spectrophotometer. Dapagliflozin and Vildagliptin Retention times were found to be 3.5 and 2.1 minutes, respectively. The established method was validated in accordance with ICH Q2 (R1) methods. The Linearity was determined from 0.032:0.32 to 10:100µg/ml. The Percentage RSD was found to be less than 2% which was found to be within the limits. The Accuracy was found to be between 98 to 102% which was found to be within the limits. The robustness data was done by increasing and decreasing the flow rate between 0.6ml and 0.7ml. For the RP-HPLC technique, the concentration range from micrograms/ml yields linear responses. </p>
      </abstract>
      <kwd-group>
                <kwd>RP-HPLC</kwd>
                <kwd>Orthro phosphoric acid</kwd>
                <kwd>Acetonitrile</kwd>
                <kwd>Flowrate</kwd>
                <kwd>Runtime</kwd>
              </kwd-group>
    </article-meta>
  </front>
</article>